Allspring Global Investments
REPL icon

Allspring Global Investments’s Replimune Group REPL Stock Holding History

Allspring Global Investments’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,030
Closed -$70.4K – 2876
2023
Q2 		$70.4K Sell
3,030
-573
-16% -$11.2K ﹤0.01% 2182
2023
Q1 		$63.6K Buy
+3,603
New +$85.7K ﹤0.01% 2205

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Allspring Global Investments's REPL Position: Q3 2023 in Review

Allspring Global Investments sold out of Replimune Group (REPL) in Q3 2023, closing a stake of 3,030 shares — an estimated $70.4K sold.

Allspring Global Investments first reported a position in REPL in Q1 2023 and held it in 2 quarters. The position peaked at $70.4K in Q2 2023. 127 funds tracked by Wall St. Rank hold REPL as of Q3 2023.

  • Allspring Global Investments reported no remaining Replimune Group position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 3,030 Replimune Group shares in Q3 2023, an estimated $70.4K.
  • Allspring Global Investments first reported a position in Replimune Group in Q1 2023 and held it in 2 quarters.
  • Allspring Global Investments's Replimune Group position peaked at $70.4K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Replimune Group as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.